A naturally occurring feline model of head and neck squamous cell carcinoma

Jackie M Wypij1

  • 1Department of Veterinary Clinical Medicine, University of Illinois at Urbana-Champaign, Hazelwood Drive, Urbana, IL 61802, USA.

Insights

Feline oral squamous cell carcinoma (FOSCC) offers a relevant animal model for human head and neck squamous cell carcinoma (HNSCC). This spontaneous model shares similar disease characteristics, potentially improving cancer drug development and clinical translation.

Area of Science:

  • Comparative oncology
  • Translational cancer research
  • Veterinary medicine

Background:

  • Translating preclinical cancer research to human clinical application remains challenging due to limitations in current animal models.
  • Existing models often fail to predict drug toxicity or efficacy in human cancer patients.
  • Spontaneous animal tumor models offer greater biological relevance for studying human cancers.

Purpose of the Study:

  • To introduce feline oral squamous cell carcinoma (FOSCC) as a novel and biologically relevant spontaneous tumor model for human head and neck squamous cell carcinoma (HNSCC).
  • To highlight the shared etiopathogenesis, molecular markers, and clinical characteristics between FOSCC and HNSCC.

Main Methods:

  • Comparative analysis of etiopathogenesis, molecular markers (e.g., EGFR, VEGF, p53), tumor biology, clinical outcomes, treatment, and prognosis between FOSCC and HNSCC.
  • Evaluation of FOSCC as a spontaneous disease model for translational cancer research.

Main Results:

  • FOSCC and HNSCC share similar risk factors, including tobacco and papillomavirus exposure.
  • Key molecular markers such as EGFR, VEGF, and p53 are conserved between feline and human oral cancers.
  • Both species exhibit comparable tumor biology, clinical progression, and treatment responses.

Conclusions:

  • Feline oral squamous cell carcinoma (FOSCC) represents a promising, naturally occurring animal model for human head and neck squamous cell carcinoma (HNSCC).
  • The shared biological and clinical similarities between FOSCC and HNSCC can facilitate the translation of preclinical findings into effective human cancer therapies.
  • Utilizing FOSCC in future clinical trials may accelerate the development of novel therapeutics for human cancer patients.

Related Concept Videos